fluorouracil has been researched along with tocotrienols in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aota, K; Azuma, M; Kani, K; Momota, Y; Takano, H; Yamamura, Y; Yamanoi, T | 1 |
| Hansen, TF; Havelund, BM; Jensen, LH; Lindebjerg, J; Rafaelsen, SR; Raunkilde, L; Thomsen, CB | 1 |
1 trial(s) available for fluorouracil and tocotrienols
| Article | Year |
|---|---|
Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Middle Aged; Oxaliplatin; Rectal Neoplasms; Tocotrienols; Young Adult | 2023 |
1 other study(ies) available for fluorouracil and tocotrienols
| Article | Year |
|---|---|
γ-Tocotrienol prevents 5-FU-induced reactive oxygen species production in human oral keratinocytes through the stabilization of 5-FU-induced activation of Nrf2.
Topics: Antimetabolites, Antineoplastic; Antioxidants; Cell Line; Cell Nucleus; Cell Proliferation; Fluorouracil; Gene Expression Regulation; Humans; Keratinocytes; Mouth; NF-E2-Related Factor 2; Reactive Oxygen Species; Stomatitis; Tocotrienols | 2015 |